(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon. Simponi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results